MedPath

Diabetes Management Intervention For South Asians

Not Applicable
Completed
Conditions
HbA1c
Diabetes
Interventions
Behavioral: HIT-enabled
Behavioral: Community Health Worker (CHW)-led health
Behavioral: Physician enabled care coordination
Registration Number
NCT03333044
Lead Sponsor
NYU Langone Health
Brief Summary

The goal of this study is to evaluate the effectiveness and implementation process of a multi-level, integrated intervention to decrease HbA1c among South Asians with uncontrolled diabetes, including four components: 1) an EHR-based registry function to increase identification of South Asian patients with uncontrolled diabetes; 2) CHW-led health coaching of registered patients to promote health behavior change; 3) HIT-enabled and CHW-facilitated identification and referral to culturally relevant community resources for patients; and 4) HIT-enabled care coordination between the CHW and other members of the healthcare team.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
859
Inclusion Criteria
  • South Asian ethnicity (identified through a race and language code available in the EHR);
  • an appointment with a physician for routine non-emergent primary care in the last 12 months
  • diagnosis of diabetes
  • an HbA1c reading of >7 in the last 12 months
Exclusion Criteria
  • Pregnant women and visits to obstetrician/gynecologist are excluded from the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
HIT-enabled & CHW ledHIT-enabledSupportive care enabled by mobile devices.
CHW & Physician FeedbackPhysician enabled care coordinationPatient setting progress communicated to physician via PHI
CHW-led health coachingCommunity Health Worker (CHW)-led healthGroup sessions
CHW & Physician FeedbackCommunity Health Worker (CHW)-led healthPatient setting progress communicated to physician via PHI
Primary Outcome Measures
NameTimeMethod
Percentage of Participants who had a 0.5% reduction in HbA1cBaseline, Month 6

Measured via complete lipoprotein panel.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

One Park Avenue

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath